ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Intracavernosal injection therapy in erectile dysfunction
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 252243" data-attributes="member: 13851"><p>LOL!</p><p></p><p><strong>*</strong><em><strong>The first introduction of intracavernosal injection (ICI) for the treatment of erectile failure was in 1982 by Dr. Ronald Virag, a cardiovascular surgeon, who reported the positive effects of papaverine on erectile tissue [4]. Dr. Giles Brindley was concurrently conducting research on the effectiveness of phenoxybenzamine as an ICI therapy for ED [5].</strong> <strong>His findings were published shortly after Virag; however, Brindley is most famous for his personal demonstration of ICI therapy’s efficacy while at the 1983 American Urological Association’s (AUA) Annual Meeting in Las Vegas, where he performed ICI on himself, using various vasoactive agents prior to his speech to give visual proof to his hypothesis</strong></em></p><p></p><p></p><p></p><p><strong>The Hour Lecture That Changed Sexual Medicine—The Giles Brindley Injection Story (2012)</strong></p><p><em>Irwin Goldstein, MD Editor-in-Chief, Journal of Sexual Medicine</em></p><p></p><p></p><p><strong>Figure 1 Giles Brindley lecture at 7:00–8:00 PM on Monday, April 18th, 1983. Few remember anything about the presentations of the other 12 speakers.</strong></p><p><strong>[ATTACH=full]30880[/ATTACH]</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Figure 2 (a) Handwriting of Dr. G.S. Brindley describing the dose and the medication used to achieve the erection at the AUA meeting in 1983. (b) The handwriting of Dr. G.S. Brindley lists his publication that was in press at the time.</strong></p><p><strong>[ATTACH=full]30881[/ATTACH]</strong></p><p><strong>[ATTACH=full]30882[/ATTACH]</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Figure 3 Photos of Giles Brindley sent by his colleagues. </strong></p><p><strong>[ATTACH=full]30883[/ATTACH]</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Biographical sketch: Giles Brindley, FRS (2012)</strong></p><p><em>Jacob Kan, Tipu Z. Aziz, Alexander L. Green & Erlick A. C. Pereira</em></p><p></p><p></p><p><strong>Fig. 1. Giles Skey Brindley, FRS.</strong></p><p><strong>[ATTACH=full]30884[/ATTACH]</strong></p></blockquote><p></p>
[QUOTE="madman, post: 252243, member: 13851"] LOL! [B]*[/B][I][B]The first introduction of intracavernosal injection (ICI) for the treatment of erectile failure was in 1982 by Dr. Ronald Virag, a cardiovascular surgeon, who reported the positive effects of papaverine on erectile tissue [4]. Dr. Giles Brindley was concurrently conducting research on the effectiveness of phenoxybenzamine as an ICI therapy for ED [5].[/B] [B]His findings were published shortly after Virag; however, Brindley is most famous for his personal demonstration of ICI therapy’s efficacy while at the 1983 American Urological Association’s (AUA) Annual Meeting in Las Vegas, where he performed ICI on himself, using various vasoactive agents prior to his speech to give visual proof to his hypothesis[/B][/I] [B]The Hour Lecture That Changed Sexual Medicine—The Giles Brindley Injection Story (2012)[/B] [I]Irwin Goldstein, MD Editor-in-Chief, Journal of Sexual Medicine[/I] [B]Figure 1 Giles Brindley lecture at 7:00–8:00 PM on Monday, April 18th, 1983. Few remember anything about the presentations of the other 12 speakers. [ATTACH type="full"]30880[/ATTACH] Figure 2 (a) Handwriting of Dr. G.S. Brindley describing the dose and the medication used to achieve the erection at the AUA meeting in 1983. (b) The handwriting of Dr. G.S. Brindley lists his publication that was in press at the time. [ATTACH type="full"]30881[/ATTACH] [ATTACH type="full"]30882[/ATTACH] Figure 3 Photos of Giles Brindley sent by his colleagues. [ATTACH type="full"]30883[/ATTACH] Biographical sketch: Giles Brindley, FRS (2012)[/B] [I]Jacob Kan, Tipu Z. Aziz, Alexander L. Green & Erlick A. C. Pereira[/I] [B]Fig. 1. Giles Skey Brindley, FRS. [ATTACH type="full"]30884[/ATTACH][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Intracavernosal injection therapy in erectile dysfunction
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top